JPRN-UMIN000043115
Recruiting
未知
Coronary Plaque Characterization by Near-infrared Spectroscopy for Identification of Plaque Vulnerability: Association with Coronary Computed Tomographic Angiography - Coronary Plaque Characterization by NIRS: Association with CCTA
ConditionsIschemic Heart Disease
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Ischemic Heart Disease
- Sponsor
- Gifu Heart Center
- Enrollment
- 200
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\.Prior coronary revascularization therapy (PCI and/or CABG) to target vessel 2\.STEMI within the past 24 hours 3\.Simultaneously treated with multi\-vesssel PCI on initial procedure 4\.LMT case 5\.Chronic kidney disease (serum creatinine on admission more than 1\.5 mg/dl) 6\.Presented with hemodynamic instability (cardiogenic shock) 7\.Complex lesion which need to do balloon dilatation (more than 2\.0mm balloon or debulking device before pre\-procedural NIRS\-IVUS 8\.Poor image quality case which the technician cannot perform either CTA or NIRS\-IVUS measurements 9\.Lesions with an EEM diameter \<2\.0mm
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Coronary Plaque Characterization by Near-infrared Spectroscopy for Identification of Plaque Vulnerability: Association with Coronary Computed Tomographic AngiographyIschemic Heart DiseaseJPRN-UMIN000042883Gifu Heart Center120
Completed
Not Applicable
Coronary Artery Plaque Characterisation with Non-invasive Multi-Slice Computed Tomography and Invasive Intravascular Ultrasound and Optical Coherence Tomography in Patients with Acute Coronary Syndromes Without ST-segment Elevatioatherosclerosis10011082NL-OMON36442niversitair Medisch Centrum Groningen50
Completed
Phase 2
SPECTACL: SPECTroscopic Assessment of Coronary LipidAngina PectorisAngina, UnstableMyocardial InfarctionNCT00330928Infraredx106
Completed
Phase 3
High-Resolution Assessment of Coronary Plaques in a Global Evolocumab Randomized Study (HUYGENS)anginaheart attackhigh blood lipidshigh cholesterolVessels supplying the heart with blood1001108210013317NL-OMON48805Amgen43
Active, not recruiting
Phase 1
Imaging of Coronary Plaques in Subjects Treated With EvolocumabEUCTR2017-003236-37-DEAmgen Inc.150